As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/8/24  Aadi Bioscience, Inc.             10-Q        3/31/24   69:6.6M                                   Workiva Inc Wde… FA01/FA 
  5/8/24  Aadi Bioscience, Inc.             8-K:2,9      5/8/24   11:245K                                   Workiva Inc Wde… FA01/FA 
  5/3/24  Aadi Bioscience, Inc.             424B5                  1:219K                                   Donnelley … Solutions/FA 
  5/1/24  Desai Neil                        4          Dir.,Off.²  1:6K   Aadi Bioscience, Inc.             SEC Connect              
 4/30/24‡ Aadi Bioscience, Inc.             EFFECT      4/30/24    1:2K                                     SEC #5                   
 4/26/24  Aadi Bioscience, Inc.             ARS        12/31/23    1:13M                                    Donnelley … Solutions/FA 
 4/26/24  Ball Bryan                        3          Officer²    2:14K  Aadi Bioscience, Inc.             SEC Connect              
 4/26/24  Aadi Bioscience, Inc.             DEFA14A                1:1.2M                                   Workiva Inc Wde… FA01/FA 
 4/26/24  Aadi Bioscience, Inc.             DEF 14A     6/11/24   12:3.4M                                   Workiva Inc Wde… FA01/FA 
  4/4/24  Aadi Bioscience, Inc.             8-K:1        4/1/24   10:143K                                   Workiva Inc Wde… FA01/FA 
  4/3/24  Desai Neil                        4          Dir.,Off.²  1:7K   Aadi Bioscience, Inc.             SEC Connect              
 3/13/24  Aadi Bioscience, Inc.             10-K       12/31/23   81:12M                                    Workiva Inc Wde… FA01/FA 
 3/13/24  Aadi Bioscience, Inc.             8-K:2,9     3/13/24   11:271K                                   Workiva Inc Wde… FA01/FA 
  3/4/24  Desai Neil                        4          Dir.,Off.²  1:7K   Aadi Bioscience, Inc.             SEC Connect              
  3/4/24  Itri Lorettta M                   4          Officer²    1:9K   Aadi Bioscience, Inc.             SEC Connect              
  3/4/24  Lennon David James                4          Dir.,Off.²  1:9K   Aadi Bioscience, Inc.             SEC Connect              
  3/4/24  Giacobello Scott M.               4          Officer²    1:9K   Aadi Bioscience, Inc.             SEC Connect              
  3/1/24  Desai Neil                        144                    2:97K  Aadi Bioscience, Inc.             Charles Schwab … Svcs/FA 
 2/12/24  Aadi Bioscience, Inc.             S-8         2/12/24    4:95K                                    Donnelley … Solutions/FA 
 2/12/24  Aadi Bioscience, Inc.             S-3                    4:622K                                   Donnelley … Solutions/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	144	Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
	424B5	Prospectus – Primary Offering or Shelf Securities – New Facts or Events.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	EFFECT	SEC Notice of Effectiveness.
	S-3	Registration Statement – Securities for a Transaction — Form S-3.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.